New Study Shows Sharp Drop in Cervical Cancer Among Younger Women

By Adebowale Bello. B.Tech Microbiology. DLHA Fellow. Medically reviewed by the DLHA Team.

May 27, 2026.

A group of young African women posing in photo while sitting together on a bench outdoor. Image Credit: Magnific

Cervical cancer remains one of the most common cancers affecting women globally, and it is especially concerning in many African countries where access to screening and prevention is still limited. Over the years, health experts have introduced different strategies to reduce this burden, including routine screening and, more recently, vaccination against the human papillomavirus (HPV), which is the main cause of cervical cancer.

A new study published in the Journal of the National Cancer Institute takes a closer look at how cervical cancer rates have changed across different generations of women, particularly before and after the introduction of the HPV vaccine. The findings give a clearer picture of what is working and what still needs attention.

About the Study

The study analysed cervical cancer trends in the United States using a large national dataset. Researchers used a method called age–period–cohort analysis to track how the risk of cervical cancer has changed among women born in different years.

They focused on women aged 30 to 31 and examined birth cohorts from as far back as 1917 up to the early 2000s. This approach allowed them to separate the effects of time, age and generation, which is important when studying long-term diseases like cancer.

The goal was to understand whether the introduction of HPV vaccination has had any measurable impact on cervical cancer rates at a population level.

What the Study Found

• A steady decline that slowed over time

The study found that cervical cancer rates had been declining for many decades. For women born up to the early 1950s, the risk dropped by about 1.9 percent per birth year.

However, this progress slowed significantly in later generations. For women born after the 1950s, the decline reduced to about 0.3 percent per year.

This suggests that earlier improvements were largely driven by screening methods such as Pap smears, which help detect abnormal cells early before they develop into cancer.

• A sharp drop in younger generations

One of the most striking findings came from women born from the late 1980s onwards. Starting with those born between 1987 and 1989, cervical cancer rates dropped sharply by about 10.5 percent per birth year. This is a much faster decline than what was seen in earlier generations.

• A significant reduction in risk

When researchers compared different generations, they found that women born in the 1990s had about 54 percent lower cervical cancer rates than those born in the 1970s. This is a major reduction and points to a strong shift in disease patterns.

Why This Matters

The timing of this sharp decline is important. It aligns closely with the introduction and increasing use of the HPV vaccine.

HPV is responsible for most cervical cancer cases, and vaccines are designed to prevent infection from the high-risk types of the virus. Previous studies have already shown that HPV vaccines are highly effective at preventing infection and pre-cancerous changes.

This new study goes a step further by showing that vaccination is now beginning to reduce actual cancer cases at the population level. In simple terms, this is one of the clearest real-world signs so far that HPV vaccination is working not just in theory but in everyday life.

What the Study Means for Global Public Health

This study highlights something important. Cervical cancer is one of the few cancers that can both be prevented and controlled effectively.

There are two main tools:

• Screening to detect early changes
• Vaccination to prevent the cause

When both are used together, the impact can be dramatic.

What the Study Means for Africans

While the study was conducted in the United States, its implications are highly relevant for African countries.

1. Prevention works when systems are in place

The steady decline seen in older generations was largely due to screening. This shows that organised health systems can reduce cervical cancer even without vaccines.

However, many African countries still struggle with access to regular screening. This means many cases are detected late, when treatment is more difficult.

2. Vaccination can change the future

The sharp drop in cervical cancer cases in younger women shows the power of HPV vaccination. If similar vaccination coverage is achieved in African countries, the burden of cervical cancer, which when standardised for age is currently reported to be about 31 cases per 100,000 women, compared with 6 - 7 cases per 100,000 women in high income countries, could reduce significantly within one or two generations.

Global projections even suggest that widespread HPV vaccination could reduce cervical cancer cases by up to 89 percent over time.

3. There is a gap that needs urgent attention

Despite the high burden of cervical cancer in Africa, HPV vaccination rates remain low in many countries due to cost, access and awareness challenges. This creates a situation where regions that need the vaccine the most are the least covered.

4. Early action is critical

Another important lesson from research is that HPV vaccination works best when given at a younger age, before exposure to the virus. This means targeting adolescents, especially girls, before they become sexually active.

Delaying vaccination reduces its effectiveness at preventing cancer later in life.

Wrap Up

The study provides strong evidence that cervical cancer rates are not just declining by chance. Earlier reductions were driven by screening but the recent sharp drop in younger women is closely linked to HPV vaccination.

For African countries, this is both a warning and an opportunity because without strong vaccination and screening programmes, cervical cancer will continue to affect many women. However, with the right policies, awareness and investment, the trend can change.

Cervical cancer does not have to remain a major public health problem because the tools to reduce it already exist. What matters now is how widely and effectively they are used.

Source: Jiang C, Rosenberg PS, Star J, Bandi P, Bednarczyk RA, Jemal A, Sung H. State-level progress in reducing cervical cancer incidence among US young women between the pre- and post-human papillomavirus vaccination eras. J Natl Cancer Inst. 2026 Feb 24. Available from here

Related:

Cervical Cancer Screening Information for African women

Challenges Of Cervical Cancer Prevention And Care In Africa

Cervical cancer treatment and the challenges for African women

HPV Vaccine Protects the Unvaccinated, Study Shows

Why African Girls Need the HPV Vaccine

Published: May 27, 2026.

© 2026. Datelinehealth Africa Inc. All rights reserved.

Permission is given to copy, use and share content for non-commercial purposes without alteration or modification and subject to source attribution.